Page 27 of 28
The Journal of Organic Chemistry
1
product 13 (1.16 g, 3.37 mmol, 67%) as brownish oil. Rf (cyclohexane-ethyl acetate 1:1) = 0.35; H NMR CDCl3, 400 MHz, δ
(ppm) 1.31 (t, J = 7.1 Hz, 3H), 3.80 (s, 6H), 4.15 (q, J = 7.1 Hz, 2H), 6.89 (d, J = 8.7 Hz, 4H), 7.21-7.26 (m, 4H); 13C {1H} NMR
CDCl3, 100 MHz, δ (ppm) 14.8, 55.7, 61.2, 114.8, 126.6, 129.2, 158.0, 164.9; IR (cm-1) 2970, 1738, 1542, 1597, 1509, 1464, 1441,
1371, 1297, 1229, 1180, 1094, 1033, 904, 829, 799, 729; HRMS (ESI): calculated for C18H22N3O4 [M+H]+: 344.1610, found:
344.1595.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Supporting Information
See Supporting Information for copies of in situ IR-Spectra, LC-MS chromatograms and copies of 1H and 13C NMR spectra.
REFERENCES
1
2
3
Alonso-Moreno, C.; Antinolo, A.; Carrillo-Hermosilla, F.; Otero, A. Chem. Soc. Rev. 2014, 43, 3406–3425.
Saczewski, F.; Balewski, Ł. Expert Opin. Ther. Patents 2009, 19, 1417–1448.
a) Greenhill, J. V.; Lue, P. Progress in Medicinal Chemistry 1993, 30, 203–326; b) Berlinck, R. G. S.; Trindade-Silva, A. E.; Santos, M.
F. C. Nat. Prod. Rep. 2012, 29, 1382–1406;
4
5
Gallivan, J. P.; Dougherty, D. A. Proc. Natl. Acad. Sci. USA 1999, 96, 9459–9464.
Ishikawa, T., Superbases for Organic Synthesis. Guanidines, Amidines, Phosphazenes and Related Organocatalysts, J. Wiley & Sons,
Sussex, UK, 2009; 1. Aufl.
6
7
Schenck, M. Hoppe-Seyler's Z. Physiol. Chem. 1912, 77, 370.
a) Barton, D. H. R.; Elliott, J. D.; Géro, S. D. J. Chem. Soc. Chem. Comm. 1981, 1136–1137; b) Barton, D. H. R.; Elliott, J. D.; Géro, S. D.
J. Chem. Soc., Perkin Trans. 1 1982, 2085–2090;
8
a) Taylor, J. E.; Bull, S. D.; Williams, J. M. J. Chem. Soc. Rev. 2012, 41, 2109–2121; b) Fu, X.; Tan, C.-H. Chem. Commun. 2011, 47, 8210–
8222; c) Leow, D.; Tan, C.-H. Chem. Asian J. 2009, 4, 488–507; d) Ishikawa, T.; Kumamoto, T. Synthesis 2006, 737–752; e) Dalko, P.
I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138–5175; f) T. Ishikawa, T. Isobe Chem. Eur. J. 2002, 8, 552–557;
Bailey, P. J.; Pace, S. Coord. Chem. Rev. 2001, 214, 91–141.
9
10 a) Doroodian, A.; Dengler, J. E.; Genest, A.; Rösch, N.; Rieger, B. Angew. Chem. Int. Ed. 2010, 49, 1871–1873; b) Lin, L.; Li, Y.; Zhang,
S.; Li, S. Synlett 2011, 1779–1783;
11
a) Goswami, S.; Jana, S.; Chakrabarty, R.; Fun, H.-K. Supramol. Chem. 2010, 22, 143–148; b) Späth, A.; König, B. Tetrahedron 2010,
66, 6019–6025;
12
13
Miyake, M.; Nishikawa, T.; Abe, M. J. Oleo Sci. 2010, 59, 101–108.
Millward, S. W.; Henning, R. K.; Kwong, G. A.; Pitram, S.; Sharpless, K. B.; Heath, J. R. J. Am. Chem. Soc. 2011, 133, 18280–18288.
14 a) Radchatawedchakoon, W.; Watanapokasin, R.; Krajarng, A.; Yingyongnarongkul, B.-e. Bioorg. Med. Chem. 2010, 18, 330–342; b)
Som, A.; Xu, Y.; Tew, G. N.; Scott, R. W. Org. Biomol. Chem. 2012, 10, 40–42; c) Zhang, Q.; Li, S.; Zhang, S. Chem. Commun. 2010,
46, 7495–7497;
15
a) Murtaza, G.; Badshah, A.; Said, M.; Khan, H.; Khan, A.; Khan, S.; Siddiq, S.; Choudhary, M. I.; Boudreauc, J.; Fontaine, F.-G.
Dalton Trans. 2011, 40, 9202–9211; b) Murtaza, G.; Rauf, M. K.; Badshah, A.; Ebihara, M.; Said, M.; Gielen, M.; de Vos, D.; Dilshad,
E.; Mirza, B. Eur. J. Med. Chem 2012, 48, 26–35;
16 a) Smejkal, T.; Breit, B. Angew. Chem. Int. Ed. 2008, 47, 311–315; b) Fuchs, D.; Rousseau, G.; Diab, L.; Gellrich, U.; Breit, B. Angew.
Chem. Int. Ed. 2012, 51, 2178–2182;
17
Ghorai, P.; Kraus, A.; Keller, M.; Götte, C.; Igel, P.; Schneider, E.; Schnell, D.; Bernhardt, G.; Dove, S.; Zabel, M. et al. J. Med. Chem
2008, 51, 7193–7204.
18 a) Cole, D. C.; Manas, E. S.; Stock, J. R.; Condon, J. S.; Jennings, L. D.; Aulabaugh, A.; Chopra, R.; Cowling, R.; Ellingboe, J. W.; Bard,
J. J. Med. Chem 2006, 49, 6158–6161; b) Fobare, W. F.; Solvibile, W. R.; Robichaud, A. J.; Malamas, M. S.; Manas, E.; Turner, J.; Hu,
Y.; Wagner, E.; Chopra, R.; Cowling, R. et al. Bioorg. Med. Chem. Lett. 2007, 17, 5353–5356; c) Jennings, L. D.; Cole, D. C.; Stock, J. R.;
Sukhdeo, M. N.; Bard, J. Bioorg. Med. Chem. Lett. 2008, 18, 767–771;
19 a) Aihara, K.; Hisa, H.; Sato, T.; Yoneyama, F.; Sasamori, J.; Yamaguchi, F.; Yoneyama, S.; Mizuno, Y.; Takahashi, A.; Nagai, A. et al.
Eur. J. Pharmacol. 2000, 404, 221–229; b) Padmanabhan, S.; Lavin, R. C.; Thakker, P. M.; Guo, J.; Zhang, L.; Moore, D.; Perlman, M.
E.; Kirk, C.; Daly, D.; Burke-Howie, K. J. et al. Bioorg. Med. Chem. Lett. 2001, 11, 3151–3155;
20 Moritomo, A.; Yamada, H.; Watanabe, T.; Itahana, H.; Akuzawa, S.; Okada, M.; Ohta, M. Bioorg. Med. Chem. 2013, 21, 7841–7852.
21
Adang, A. E. P.; Lucas, H.; de Man, A. P. A.; Engh, R. A.; Grootenhui, P. D. J. Bioorg. Med. Chem. Lett. 1998, 8, 3603–3608.
22 Pape, S.; Wessig, P.; Brunner, H. RSC Adv. 2015, 5, 101408–101411.
23 for review articles on guanylation reactions see: 1 and a) Zhang, W.-X.; Xu, L.; Xi, Z. Chem. Commun. 2015, 51, 254–265; b) Xu, L.;
Zhang, W.-X.; Xi, Z. Organometallics 2015, 34, 1787–1801; c) Rauws, T. R. M.; Maes, B. U. W. Chem. Soc. Rev. 2012, 41, 2463–2497; d)
Katritzky, A. R.; Rogovoy, B. V. ARKIVOC 2005, 6, 49–87; for recent selected examples, see: e) Zhu, T.-H.; Wang, S.-Y.; Wei, T.-Q.;
Ji, S.-J. Adv. Synth. Catal. 2015, 357, 823–828; f) Tsubokuraa, K.; Iwataa, T.; Taichia, M.; Kurbangalievad, A.; Fukasec, K.; Nakaob, Y.;
Tanaka, K. Synlett 2014, 25, 1302–1306; g) Li, J.; Neuville, L. Org. Lett. 2013, 15, 6124–6127; h) Maestri, G.; Larraufie, M.-H.; Ollivier,
27
ACS Paragon Plus Environment